Background/Aims: Formyl peptide receptors (FPRs) recognize different endogenous and exogenous molecular stimuli and mediate neutrophil activation. Dysregulation of excessive neutrophil activation and the resulting immune responses can induce acute lung injury (ALI) in the host. Accordingly, one promising approach to the treatment of neutrophil-dominated inflammatory diseases involves therapeutic FPR1 inhibition. Methods: We extracted a potent FPR1 antagonist from Garcinia multiflora Champ. (GMC). The inhibitory effects of GMC on superoxide anion release and elastase degranulation from activated human neutrophils were determined with spectrophotometric analysis. Reactive oxygen species (ROS) production and the FPR1 binding ability of neutrophils were assayed by flow cytometry. Signaling transduction mediated by GMC in response to chemoattractants was assessed with a calcium influx assay and western blotting. A lipopolysaccharide (LPS)-induced ALI mouse model was used to determine the therapeutic effects of GMC in vivo. Results: GMC significantly reduced superoxide anion release, the reactive oxidants derived therefrom, and elastase degranulation mediated through selective, competitive FPR1 blocking in N-formyl-l-methionyl-l-leucyl-lphenylalanine (fMLF)-stimulated human neutrophils. In cell-free systems, GMC was unable to scavenge superoxide anions or suppress elastase activity. GMC produced a right shift in fMLF-activated concentration-response curves and was confirmed to be a competitive FPR1 antagonist. GMC binds to FPR1 not only in neutrophils, but also FPR1 in neutrophil-like THP-1 and hFPR1-transfected HEK293 cells. Furthermore, the mobilization of calcium and phosphorylation of mitogen-activated protein kinases and Akt, which are involved in FPR1-mediated downstream signaling, was competitively blocked by GMC. In an in vivo study, GMC significantly reduced pulmonary edema, neutrophil infiltration, and alveolar damage in LPSinduced ALI mice. Conclusion: Our findings demonstrate that GMC is a natural competitive FPR1 inhibitor, which makes it a possible anti-inflammatory treatment option for patients critically inflicted with FPR1-mediated neutrophilic lung damage.
Introduction
Inflammation is a physical defense response to microorganism infection and pathologic progression that is largely mediated by neutrophil recruitment and activation [1] . However, dysregulation of neutrophil activation can be harmful to major organs and has been associated with the pathogenesis of many clinical diseases, such as acute lung injury (ALI), acute respiratory distress syndrome (ARDS), Alzheimer's disease, autoimmune diabetes, and rheumatoid arthritis [2] [3] [4] [5] . As ALI and ARDS develop, a large number of neutrophils are activated and recruited into inflamed lungs. Poorly regulated neutrophils release massive quantities of superoxide anions and proteolytic enzymes, which can damage the alveolar capillary barrier and hinder pulmonary gas exchange [6] . Despite the development of numerous therapeutic strategies, mortality rates remain high among patients with ALI and ARDS [7] .
G protein-coupled formyl peptide receptor 1 (FPR1) is a transmembrane receptor primarily found in neutrophils. These receptors are responsible for sensing various endogenous and exogenous molecular stimuli to mediate neutrophil activation during inflammation [8, 9] . N-formyl peptides derived from invading microorganisms or endogenous host mitochondria strongly bind to FPR1 to trigger septic or sterile inflammatory responses [10, 11] . The binding of N-formyl peptides to FPR1 activates neutrophils and guides their migration into infected or injured tissues. Recent cellular and animal studies have proven the therapeutic effects of FPR1 antagonists [12, 13] . Blockade of FPR1 reduces many of the essential functions of neutrophils associated with defense, such as superoxide anion generation, elastase release, chemotaxis, and phagocytosis [14] . One previous study reported that trauma hemorrhagic shock-induced lung damage and systemic inflammatory response syndrome in rats are associated with endogenous mitochondrial N-formyl peptides, which can be alleviated by the administration of FPR inhibitors [15] . Grommes [16] revealed that exogenous endotoxin induced FPR1-mediated lung neutrophil infiltration, with relief provided by FPR1 knockout. FPR1 antagonists also decrease neutrophil infiltration in cases of lipopolysaccharide (LPS)-induced ALI [13] .
FPR1 antagonists are an emerging therapeutic target in the development of drugs to combat neutrophilic lung inflammation. However, only a few FPR1 antagonists have been studied [12] . Our research team examined the anti-inflammatory effects of extracts from the fruit of the evergreen Garcinia multiflora Champ., which is endemic to Taiwan, Hong Kong, and southern China. We named the fruit extraction from Garcinia multiflora Champ. as GMC. Studies have reported that G. multiflora has anti-inflammatory [17] and anti-HIV activity [18] . We previously reported that pure compounds from G. multiflora inhibit the generation of superoxide anions and elastase release in fMLF-stimulated neutrophils [17, 19] . Nonetheless, the pharmacological mechanisms and therapeutic effects of GMC remain to be elucidated.
In this study, we investigated the anti-inflammatory roles of GMC by conducting in vitro studies of neutrophil activation and an in vivo study of LPS-induced ALI in mice. Our results revealed that GMC significantly suppresses superoxide anion production, the reactive Tsai et al.: A Novel FPR1 Antagonist GMC Inhibits Neutrophilic Inflammation oxidants derived therefrom, and elastase degranulation in N-formyl peptide-stimulated neutrophils by selectively binding to FPR1 to block calcium mobilization as well as mitogenactivated protein kinase (MAPK) and Akt activation. Administration of GMC also greatly reduced endotoxin-induced ALI in mice, indicating GMC as a clinical therapeutic option for the treatment of neutrophil-related pulmonary inflammation.
Materials and Methods

Plant extraction
The dried fruit of G. multiflora (3 kg) was cut into small pieces and immersed in MeOH (3 × 10 L) for 3 days for sequential extraction. Residue (330 g) was concentrated from MeOH extracts under vacuum and then partitioned into EtOAc and H 2 O. Residue Fraction A (167 g) was concentrated from the EtOAc layer. After obtaining chromatographs from samples on silica gel, we subjected 120 g of Fraction A to elution using CH 2 Cl 2, which yielded 77 mg of GMC.
Reagents
Trp-Lys-Tyr-Met-Val-D-Met-NH 2 (WKYMVm) was obtained from Tocris Bioscience (Ellisville, MO). Fluo-3/AM and N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein (FNLFNYK) were obtained from Molecular Probes (Eugene, OR). Methoxysuccinyl-Ala-Ala-Pro-Val-nitroanilide, rolipram, and N-[2-(p-Bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H89) were purchased from Calbiochem (San Diego, CA). Water soluble tetrazolium-1 (WST-1) was purchased from Dojindo Laboratories (Kumamoto, Japan). Cyclic adenosine monophosphate (cAMP) immunoassay kits were obtained from GE Healthcare (Uppsala, Sweden). The antibody for p38 MAPK was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and other antibodies were obtained from Cell Signaling Technology (Danvers, MA). All other pharmacologic materials were purchased from Sigma-Aldrich (St. Louis, MO).
Human neutrophil preparation
All human research protocols were examined by the Institutional Review Board of Chang Gung Medical Foundation. Healthy volunteers who had not been taking any medication within at least the 2 previous weeks provided informed consent prior to enrollment in the study. Blood samples were donated only from healthy young people (20-30 years of age). Buffy coats containing neutrophils were obtained from donated whole blood using a dextran sedimentation assay, as described in [20] . The buffy coats were then collected using differential centrifugation in a Ficoll Hypaque. Erythrocytes were lysed using a hypotonic solution on ice. Samples were washed and resuspended in iced Hank's balanced salts solution (HBSS) to obtain viable neutrophils of no less than 98% purity.
Cell culture THP-1 cells were grown in Roswell Park Memorial Institute medium 1640 supplemented with glutamine (2 mM), fetal bovine serum (FBS, 10%), and antibiotics. THP-1 cells then underwent induced cell differentiation using dibutyryl cAMP (300 μM) for 2 days before being centrifuged and resuspended in growth medium [13] .
HEK293 cells were cultured in Dulbecco's modified Eagle's medium containing FBS (10%), glutamine (2 mM), and antibiotics. HEK293 cells were transfected with the human FPR1 gene (NM_002029; OriGene, Rockville, MD) using a pCMV6-AC vector for 3 days in accordance with the manufacturer's instructions [13] .
Determination of superoxide anion and reactive oxygen species production
The extracellular superoxide anion levels in neutrophils were determined using a spectrophotometer (U-3010; Hitachi, Tokyo) and are expressed as the reduction in the quantity of ferricytochrome c. Following pre-incubation with ferricytochrome c, neutrophils were primed with or without cytochalasin B at 37°C for 3 min. For cell activation, neutrophils were pretreated with vehicle (dimethyl sulfoxide [DMSO]) or GMC for 5 min followed by a 10-min stimulation with fMLF (FPR1 agonist), WKYMVm (FPR1/FPR2 agonist), NaF (G protein activator), or PMA (protein kinase C activator). The changes in absorbance were analyzed continuously at 550 nm by a spectrophotometer. DHR123 dye was used to probe reactive oxygen species [20] .
Measurement of elastase release
Elastase release is expressed as the eliminating ability for the substrate methoxysuccinyl-AlaAla-Pro-Val-p-nitroanilide determined by spectrophotography at 405 nm. Neutrophils pre-mixed with elastase substrate (0.1 mM) were incubated with DMSO or GMC at 37°C for 5 min and stimulated using fMLF, WKYMVm, NaF, or leukotriene B4 (LTB4, BLT1 receptor agonist). Neutrophils were primed using cytochalasin B for 3 min prior to cell activation. Data are presented as the percentages of the levels obtained from the control group [20] .
Assays of the scavenging effects of superoxide anions and dipenyl picryl hydrazyl radicals
A xanthine/xanthine oxidase system was used to evaluate the scavenging effects of superoxide anions. Test samples were incubated with WST-1 (300 μM), Tris (pH 7.4, 50 mM), and xanthine oxidase (0.02 U/ ml). Following the administration of xanthine (0.1 mM) to the sample solution, WST-1 was eliminated using superoxide anions. The radical scavenging effects are presented as the change in absorbance as determined using spectrophotography at 450 nm at 30°C. In dipenyl picryl hydrazyl (DPPH) scavenging assays, DMSO or GMC were added to the ethanol buffer of DPPH (0.1 mM). The change in absorbance was measured at 30°C at 517 nm, and the data were compared with the data obtained from the control [20] .
Analysis of the lactate dehydrogenase level
Lactate dehydrogenase (LDH) levels were detected using a commercial kit (Promega, Madison, WI). LDH levels are presented as the relative percentage of the total LDH. Total LDH levels were measured by lysing the cells using Triton X-100 (0.1%) [21] .
Receptor binding assay
Fluorescence-activated cell sorting (FACS) assays were used to characterize receptor binding [13] . A fluorescent analog of fMLF (FNLFNYK) was adopted for the analysis of binding ability to FPR1. All sample cells were pretreated for 5 min with DMSO, GMC, or fMLF and stained with FNLFNYK at 4°C. Cells were then resuspended in HBSS and analyzed using flow cytometry with fMLF as positive control.
Determination of cAMP concentrations
Neutrophils were treated with DMSO or GMC for 5 min before stimulation with fMLF, with rolipram as positive control. The assay was blocked by the administration of dodecyltrimethylammonium bromide (0.5%). Following centrifugation at 3, 000 × g, the supernatant of the samples was obtained to measure cAMP levels using a commercial enzyme immunoassay kit (Amersham Biosciences, Buckinghamshire, UK) [21] .
Determination of calcium concentrations in neutrophils
Neutrophils stained with Fluo-3/AM dye (2 μM) were used to assess calcium influx in response to chemoattractants. Cytoplasmic calcium concentrations were assayed using a spectrofluorometer at 37°C. The excitation and emission wavelengths were 488 and 520 nm, respectively. Following treatment with DMSO or GMC, fMLF, WKYMVm, or LTB4 were administered to induce calcium mobilization. The peak intracellular calcium concentration ([Ca 2+ ] i ) was calculated by determination of the fluorescence intensity based on the protocol described in our previous study [21] .
Western immunoblotting analysis
Following incubation with the vehicle control (DMSO) or GMC, neutrophils were stimulated with fMLF for 30 s or with WKYMVm, PMA, or LTB4 for 60 s. Lysates of neutrophils were obtained for western blotting analysis after separation via centrifugation at 14, 000 × g. We used 12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis to determine the levels of each protein target in each of the cytoplasmic extracts. The separated proteins were blotted onto transfer membrane and treated with primary antibodies The intensity of the blotted proteins was determined using a chemiluminescence substrate (Amersham Biosciences, Piscataway, NJ) on a UVP Biospectrum imager (UVP, Upland, CA) [13, 20] .
Experimental animals
The protocol of this study protocol was based on the instructions found in The Guide for Care and Use of Laboratory Animals issued by the Taiwanese government. C57BL/6 mice (BioLasco, Ilan, Taiwan) underwent environmental adaptation for a period of 7 days prior to the animal study.
LPS-induced ALI mouse model
Twenty-four male mice (20-25 g, 7-8 weeks old) underwent general anesthesia through the intraperitoneal administration of Zoletil 50 (30 μg/g) and Xylazine (6 μg/g). After being anesthetized, the mice were intratracheally instilled with an LPS spray (160 ng/g; Sigma-Aldrich) from E. coli (serotype 0111:B4) [13, 20] . Animals were randomly separated into groups to receive GMC (100 mg/kg) or vehicle via the intraperitoneal route 1 h prior to the induction of lung injury. The animals were divided into four groups: sham, GMC only, LPS only, and LPS+GMC. Mouse lungs were removed under anesthesia after 6 h. The left lung was fixed in buffered formalin (10%) for histologic examination. The right upper lobes were analyzed for lung water content, and the other lobes of the right lung were assayed for myeloperoxidase (MPO) activity. Water content in the lungs was characterized by the wet-to-dry weight ratio.
Measurement of MPO levels
Harvested organs were homogenized in ice-cold PBS buffer (50 mM, pH 6.0) using a homogenizer. The homogenate was centrifuged at 12, 000 × g (4°C) for 20 min and the supernatant was recovered. The level of MPO in the supernatant was characterized as the degree of oxidation of o-dianisidine dihydrochloride (Sigma-Aldrich) using a spectrophotometer at 405 nm. The results were normalized to the protein content of the samples as determined using the Bradford method (Bio-Rad Laboratories, Hercules, CA) [20] .
Histopathology examination
Lung samples were immersed in formalin (10%) for 1 day and embedded in paraffin blocks before being cut into 5-μm-thick pieces. Tissue sections were stained using hematoxylin and eosin or immunohistochemistry as described previously [20] . Formalin-fixed sections embedded in paraffin underwent immunohistochemical analysis using Ly-6G (Gr-1) protein. Ly-6G (Gr-1) is a myeloid differentiation antigen and a good indicator for the identification of peripheral neutrophils. In this experiment, we used rat anti-mouse-Ly-6G (Gr-1) monoclonal primary antibodies (eBioscience, San Diego, CA) at a 1:200 dilution for staining. Microscopic images were obtained under a light microscope.
Statistical analysis
Experiment data are presented as the mean ± standard error of the mean (SEM). Statistical analysis included the Student's t-test, one-or two-way analysis of variance, and Bonferroni's multiple-comparison test (SigmaPlot software, Systat Software, Inc., San Jose, CA). A p value < 0.05 was considered to indicate a significant difference between two groups.
Results
GMC reduces superoxide anion release, elastase degranulation, and ROS production in fMLF-stimulated human neutrophils
Respiratory burst and degranulation are the basic inflammatory responses observed in neutrophils. Our data revealed that GMC greatly reduced superoxide anion generation and elastase degranulation in fMLF-stimulated neutrophils, with half-maximal inhibitory concentration (IC 50 ) values of 3.89 ± 1.17 and 4.33 ± 0.95 ng/ml, respectively (Fig. 1A and  B) . fMLF is a selective FPR1 agonist. In flow cytometric analysis, GMC decreased intracellular ROS production in fMLF-stimulated human neutrophils (Fig. 1C) . Because GMC did not induce LDH release, even at a concentration of 2 μg/ml (data not shown), GMC is not likely
to be cytotoxic to human neutrophils. GMC was obtained via ethyl acetate extraction from a novel active fraction of a medicinal herb in conjunction with high-performance liquid chromatography (HPLC) to ensure quality control. A fingerprint chromatogram of GMC is shown in Fig. 1D . The full-scan assay revealed that separation at a wavelength of 237 nm was superior to that at other wavelengths. A group of peaks and a characteristic peak at 7.293 min of retention time were observed in the fingerprint chromatogram (Fig. 1D) . 
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GMC fails to directly scavenge superoxide anions or suppress elastase activity
We used a xanthine/xanthine oxidase system and DPPH assays to evaluate the direct effects of superoxide anion-scavenging and anti-oxidation. Even at a high dose (2 μg/ml), GMC remained nonreactive in these cell-free systems ( Fig. 2A and B) . Superoxide dismutase and α-tocopherol were used as positive controls. As shown in Fig. 2C , GMC did not have a direct effect on the inhibition of elastase activity.
GMC does not inhibit superoxide anion release or elastase degranulation in non-FPR1 agonistactivated neutrophils
To examine the anti-inflammatory effects of GMC in non-FPR1 agonist-activated neutrophils, we used WKYMVm (dual FPR1/FPR2 agonist), PMA (protein kinase C activator), LTB4 (BLT1 receptor agonist), or NaF (direct G protein activator) to trigger neutrophil functions. GMC failed to reduce superoxide anion release or elastase degranulation in non-FPR1 agonist-stimulated cells (Fig. 3) .
GMC competes with the receptor binding of the FPR1-specific ligand FNLFNYK in neutrophils
Receptor binding analysis based on flow cytometry was used to assay the FPR1 binding affinity of GMC. FNLFNYK (a fluorescently labeled FPR1 ligand) is an fMLF analog. fMLF (used as a positive control) almost entirely blocked the binding affinity of FNLFNYK to neutrophils at a dose of 10 μM. GMC notably reduced the linkage of FNLFNYK to FPR1 in a dose-dependent manner, as did the positive control fMLF (Fig. 4A and B) . The concentrationresponse curve of fMLF in superoxide production is shown in Fig. 4C . GMC showed a distinct right shift in the concentration-response curves of fMLF for superoxide anion release, confirming GMC as a competitive FPR1 inhibitor.
GMC binds FPR1 in non-neutrophil cells
The inhibition of FPR1 by GMC was reproduced in non-neutrophil cells, including dibutyryl cAMPdifferentiated THP-1 and hFPR1-transfected HEK293 cells. Again, GMC dose-dependently reduced the FPR1 binding of FNLFNYK in THP-1 and HEK293 cells (Fig. 5) . GMC showed specificity for FPR1 binding in FPR1-expressing cells. The inhibitory effects of GMC are not mediated through protein kinase A signaling cAMP/PKA has been closely associated with negative regulatory effects in human neutrophils [20] . The protein kinase A (PKA) antagonist H89 was unable to abolish the inhibitory effects of GMC on superoxide anion release and elastase degranulation (Fig. 6A  and B) . As shown in Fig. 6C , rolipram (phosphodiesterase 4 inhibitor), but not GMC, elevated intracellular cAMP concentrations in fMLF-stimulated neutrophils. Collectively, our results confirm that the suppressive effects of GMC are not associated with the cAMP/PKA signaling pathway. Fig. 3 . GMC fails to inhibit superoxide anion release and elastase degranulation in non-FPR1 agoniststimulated neutrophils. Neutrophils were treated with or without GMC (0.6-600 ng/ml) and activated with (A) WKYMVm (2 nM), (B) PMA (5 nM), (C) LTB4 (100 nM), or (D) NaF (20 mM). Superoxide anion production or elastase release was determined using spectrophotometric analysis. Experiments were conducted independently four times for A and B, five times for C, and three times for D. Values are expressed as mean ± SEM. **p<0.01, ***p<0.001 compared with the control. 
GMC specifically reduces fMLF-induced Ca 2+ mobilization in neutrophils Ca
2+ mobilization is associated with numerous inflammation-related reactions in neutrophils. Activation of G protein-coupled receptors results in two phases of calcium mobilization in neutrophils. Initially, activation of G protein-coupled receptors induces phospholipase Cβ and IP3 to trigger rapid calcium release from intracellular endoplasmic reticulum. Then, a prolonged Ca 2+ influx develops after Ca 2+ release-activated Ca 2+ channels are activated [22] . The cytosolic Ca 2+ elevation will rapidly diminish to reach basal values within several minutes [23] . We examined the effects of GMC on Ca 2+ signaling in activated neutrophils. GMC significantly reduced the [Ca 2+ ] i peak induced by fMLF in a dose-dependent manner (Fig. 7A) . In contrast, the [Ca 2+ ] i peak induced by other stimulants (WKYMVm and LTB4) was unaffected by GMC ( Fig. 7B and C) . These findings indicate that GMC specifically suppresses Ca 2+ signals in FPR1 agonist-stimulated neutrophils. The mean fluorescence intensity (MFI) was compared by reference to the control group (100%) (C) Neutrophils were treated with GMC (6 and 60 ng/ml) for 5 min. Superoxide anion production was activated using increasing concentrations of fMLF (1.0-10000 nM). All experiments were conducted independently three or four times. ***p<0.001 compared with the control. 
GMC attenuates MAPK and Akt phosphorylation with high specificity in fMLF-stimulated neutrophils
In the next experiments, we evaluated the effects of GMC on the phosphorylation of MAPK and Akt proteins. Our results revealed the rapid phosphorylation of MAPKs and Akt in fMLF-, WKYMVm-, PMA-, and LTB4-activated neutrophils. GMC specifically inhibited the fMLF-induced phosphorylation of MAPKs and Akt in human neutrophils (Fig. 8A) . GMC did not inhibit the phosphorylation of MAPKs or Akt in WKYMVm-, PMA-, or LTB4-activated human neutrophils (Fig. 8B and C) .
GMC ameliorates lung inflammation in an LPS-induced ALI mouse in vivo
Histological analysis of LPS-induced ALI in mice revealed neutrophil infiltration (Ly6G + cells), interstitial edema, and alveolar wall thickening. GMC treatment reduced neutrophil infiltration and thickening of the alveolar wall in the presence of LPS. GMC alone and sham groups showed no signs of airspace inflammation or a reduction in neutrophil infiltration. Thus, GMC reduced the effects of lung injury in an LPS-induced ALI mouse model (Fig. 9A) .
The wet-to-dry weight ratio of mouse lungs was used to indicate the degree of pulmonary edema. The calculated ratios in LPS-treated lung exceeded those of the sham groups. GMC treatment clearly mediated the increase in the wet-to-dry weight ratios in LPS-treated lungs (Fig. 9B) . Moreover, MPO activity mirrors neutrophil infiltration [24] . LPS treatment significantly increased MPO activity compared with the sham group while GMC administration significantly suppressed the increase in MPO activity in the LPS-treated groups (Fig. 9C) . 6 . cAMP/PKA signaling does not mediate the inhibitory effects of GMC. Neutrophils were pretreated with a PKA inhibitor, H89 (3 μM), prior to the addition of GMC. (A) Superoxide production and (B) elastase degranulation were stimulated using fMLF. (C) Cells were incubated with GMC (0.6-600 ng/ml) or rolipram (3 μM, positive control) with or without fMLF (100 nM). cAMP levels were measured using ELISA kits. All experiments were conducted independently three or four times. Values are expressed as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 compared with the control.
## p<0.01 versus fMLF alone. Fig. 8 . GMC significantly suppresses the phosphorylation of MAPK and Akt protein in fMLF-stimulated neutrophils. Neutrophils were treated with GMC for 5 min and then stimulated for 1 min using (A) fMLF (100 nM), (B) WKYMVm (2 nM), (C) LTB4 (100 nM), or PMA (5 nM). Phosphorylation of p38, ERK, JNK, and Akt was assessed by immunoblotting using antibodies corresponding to the target proteins. The intensity of blotted proteins was determined using a densitometer and normalized to reference values obtained from the corresponding total protein values. All experiments were conducted independently four or five times. All data are summarized as mean ± SEM compared with the control. *p<0.05, **p<0.01, ***p<0.001 versus the corresponding control group. 8
Fig. 8.
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Discussion
Exogenous pathogen infection or endogenous tissue damage induces neutrophil activation and the subsequent release of inflammatory mediators, thereby contributing to acute inflammatory responses [25, 26] . Uncontrolled or poorly regulated acute inflammation in the lung can lead to lethal ALI and ARDS. Dysregulation of excess neutrophil activation and the resulting immune responses greatly impair pulmonary endothelial function and occupy airway space during inflammation [27] . FPRs, particularly FPR1, are responsible for recognizing different endogenous or exogenous molecular stimuli in neutrophils and play a critical role in mediating neutrophil activation. A growing body of evidence supports claims that FPR1 antagonists have promising anti-inflammatory effects [28, 29] . In the present study, we demonstrate that a natural constituent extracted from G. multiflora Champ. strongly inhibits superoxide generation, elastase release, and ROS production by selectively and competitively blocking FPR1 in N-formyl peptide-stimulated cells. GMC also prevented LPS-induced ALI in our animal study. These findings suggest GMC as a novel FPR1 inhibitor that could help in the regulation of neutrophil-dominated inflammation.
GMC had concentration-dependent inhibitory effects on respiratory burst and elastase degranulation in fMLF-activated neutrophils. GMC decreased oxidative stress by limiting the extracellular release of superoxides and the intracellular generation of superoxides. In cellfree assays, we found that none of the aforementioned inhibitory effects were associated with free radical scavenging ability or drug cytotoxicity. The effects were clearly associated with FPR1-mediated downstream signaling pathways.
FPRs are G protein-coupled receptors that are expressed primarily on the cell membrane of phagocytes [8] . FPR1 and FPR2 are homologous receptors that are activated by binding to an N-formyl methionine motif, which is generated from bacterial membrane components or from endogenous mitochondria [10, 30] . Infectious and sterile inflammation can both be initiated through FPR-mediated neutrophil activation. We used the well-known synthetic N-formyl peptide, fMLF, to study the involvement of FPR1 signaling transduction in neutrophil activation. Hexapeptide WKYMVm was used to assay FPR1-and FPR2-mediated neutrophil activation [31] . PMA, LTB4, and NaF were used as non-FPR agonists for neutrophils. Our results revealed that GMC exhibits inhibitory effects only in fMLF-or WKYMVm-activated neutrophils but not in other non-FPR agonist-activated neutrophils. Moreover, receptor binding assays revealed that GMC significantly inhibited the binding of fMLF to FPR1 in activated neutrophils. GMC also presented competitive binding to FPR1 with FNLFNYK in THP-1 and hFPR1-transfected HEK293 cells. These findings suggest that GMC is a potently competitive FPR1 antagonist.
Many downstream signaling pathways are transduced by FPR1, including cAMP/PKA, calcium mobilization, MAPK, and Akt signaling [11] . The PKA inhibitor H89 is unable to abolish the inhibitory effects of GMC on fMLF-induced superoxide anion production and elastase release. FPR1-mediated neutrophil activation increases intracellular cAMP concentrations, thereby reducing respiratory burst and elastase degranulation [20, 21] . Agents mediated by PKA signaling, such as PDE4 inhibitors, synergistically increase cAMP levels in fMLFstimulated neutrophils [20, 21] . In our study, GMC showed inhibitory rather than synergistic effects in fMLF-induced increases in cAMP levels. Taken together, we can deduce that the cAMP/PKA signaling pathway is not involved in these inhibitory effects of GMC in neutrophils. We subsequently assessed the effects of the FPR1-mediated downstream signaling pathway on neutrophil activation to identify the mechanisms underlying the protective effects of GMC, including intracellular calcium mobilization, MAPK, and PI3K/Akt pathways [32] . All of these signaling pathways mediate diverse immune responses in FPR1-stimulated neutrophils [23, 32, 33] . GMC dose-dependently decreased the concentration of the peak calcium influx in fMLF-stimulated neutrophils but not in non-FPR1 agonist-stimulated neutrophils. In western blot assays, GMC had concentration-dependent inhibitory effects on MAPK and Akt phosphorylation in fMLF-stimulated neutrophils but not in WKYMVm-or LTB4-activated cells. Our results support our hypothesis that GMC inhibits fMLF-induced superoxide anion release, elastase degranulation, and ROS production in human neutrophils. The mediation of these inhibitory effects is enabled by blockade of the downstream pathways of FPR1.
N-formyl peptides may facilitate neutrophil mobilization and recruitment to sites of inflammation, resulting in lung damage [34, 35] . Chemotaxis and the migration of fMLF- [36] . FPR1 signaling facilitates neutrophil activation and infiltration in endotoxin-induced ALI, and FPR1 antagonists alleviate pulmonary damage and edema [13, 16] . In the present study, we evaluated the antiinflammatory effects and therapeutic value of GMC in a mouse model of LPS-induced ALI. LPS and fMLF are components of bacterial membranes that chemotactically attract neutrophils into inflamed lung tissue during the progression of pathogenesis. LPS triggers marked immune reactions, leading to ALI or septic shock, which have high mortality rates [37] . The severity of LPS-induced ALI is closely related to neutrophil activation and infiltration in the lung [38] . Our findings suggest that GMC decreases alveolar wall disruption, pulmonary hemorrhage and edema, and neutrophil infiltration among mice with ALI-induced LPS. Our results indicate GMC as a novel FPR1 inhibitor, with the potential to cure neutrophil-related inflammation.
Conclusion
The results obtained in this study demonstrate that GMC acts as a natural selective FPR1 inhibitor. GMC markedly suppresses the expressions of superoxide anion, reactive oxidants derived therefrom, and elastase in fMLF-stimulated human neutrophils. All inhibitory effects are mediated by blockade of FPR1 binding, which also reduces calcium mobilization and MAPK and Akt activation (Fig. 10) . Our results suggest the potential development of GMC as a therapeutic treatment for critically lethal ALI. 
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